1. Committee, N. P. Pharmacopoeia of Peoples Republic of China (China Medical Science Press Beijing, 2022).
2. Xu, Y. S., Zeng, J. G., Yu, Z. Y., Xin, W. F. & Duan, M. J. Analysis of Species and Content of Amino Acids in Fibrous Roots of Panax Notoginseng From Multiple Producing Areas in Yunnan Province Based On Hplc. Mol. Plant Breed. 1–12 (2022). http://kns.cnki.net/kcms/detail/46.1068.S.20221031.1428.014.html
3. Huang, Y. D. et al. Panax Notoginseng: A review on chemical components, chromatographicanalysis, P. Notoginseng extracts, and pharmacology in recent five years. China J. Chin. Mater. Med. 47, 2584–2596 (2022).
4. Zuo, X. H., Yin, X. N., Li, Y. Q. & Zhao, J. Q. Panax Notoginseng saponins reduces inflammation damage in diabetic osteoporosis rats by inhibiting rage/mapk signaling pathway. Chin. J. Osteoporos. 29, 343–348 (2023).
5. Zhang, H. et al. Assessing the quality ecology of endemic tree species in china based on machine learning models and uplc methods: The example of Eucommia ulmoides oliv. J. Clean. Prod. 452, 142021 (2024).